Swiss Auto Components Stock News

SWX:GALD
SWX:GALDPharmaceuticals

Galderma’s Record Sales Recast Growth Story Around Nemluvio And Aesthetics

Galderma Group (SWX:GALD) reports full year sales above $5b, marking a milestone for its dermatology focused portfolio. The company highlights new product launches it describes as having blockbuster potential across its prescription and aesthetics segments. Fresh clinical data show Nemluvio delivering long term efficacy and safety in prurigo nodularis, an area of high unmet medical need. Regulatory approval of new device technology supports further expansion of Galderma's aesthetics...
SWX:ADEN
SWX:ADENProfessional Services

A Look At Adecco Group (SWX:ADEN) Valuation After Earnings Update And Board Changes

Adecco Group (SWX:ADEN) shares are in focus after the company reported fourth quarter and full year 2025 results, along with upcoming Board changes that include planned departures and a defined end date for the current Chair. See our latest analysis for Adecco Group. The earnings and Board updates come after a weaker share price patch, with a 1-day share price return of 2.03% at CHF21.06, compared with a year-to-date share price return of 10.23% and a 1-year total shareholder return of...
SWX:VACN
SWX:VACNMachinery

VAT Group (SWX:VACN) Margin Compression Tests Bullish High‑P/E Narrative After FY 2025 Results

How VAT Group’s FY 2025 Numbers Set Up the Next Chapter VAT Group (SWX:VACN) has wrapped up FY 2025 with second half revenue of CHF 515.6 million and basic EPS of CHF 3.63, alongside trailing twelve month revenue of CHF 1.07 billion and EPS of CHF 7.15 framing the latest print. Over recent periods, the company has seen half yearly revenue move from CHF 492.6 million in 2H 2024 to CHF 515.6 million in 2H 2025, while half yearly EPS shifted from CHF 3.92 to CHF 3.63, and trailing twelve month...
SWX:ZUGN
SWX:ZUGNReal Estate

A Look At Zug Estates Holding (SWX:ZUGN) Valuation After Strong Full Year 2025 Earnings Results

What the latest earnings tell you about Zug Estates Holding Zug Estates Holding (SWX:ZUGN) just released full year 2025 figures, with sales of CHF 87.72 million, revenue of CHF 91.5 million, and net income of CHF 85.18 million drawing fresh investor attention. These headline numbers give you a fresh reference point for thinking about the stock, its current valuation, and how the business is converting its real estate and hotel activities into bottom line results. See our latest analysis for...
SWX:HIAG
SWX:HIAGReal Estate

HIAG Immobilien Holding (SWX:HIAG) FFO Slip Challenges Bullish Cash Flow Narratives

HIAG Immobilien Holding FY 2025 earnings snapshot HIAG Immobilien Holding (SWX:HIAG) has just posted its FY 2025 numbers, with first half revenue of CHF 47.6 million and basic EPS of CHF 4.42, while funds from operations came in at CHF 1.90 per share, giving investors a fresh read on both cash generation and headline profitability. Over recent periods the company has seen revenue move from CHF 70.3 million in the first half of 2024 to CHF 65.8 million in the second half of 2024 and then to...
SWX:HOLN
SWX:HOLNBasic Materials

Holcim (SWX:HOLN) Valuation Check After 2025 Earnings Lift Net Income And EPS

What Holcim’s 2025 earnings mean for shareholders Holcim (SWX:HOLN) has moved into focus after reporting full year 2025 results, with sales of CHF 15,724 million compared to CHF 16,201 million a year earlier, and a sharp jump in reported net income and earnings per share. See our latest analysis for Holcim. Despite the strong headline earnings, Holcim’s 1 month share price return of an 18.15% decline and a 14% share price pullback year to date suggest momentum has cooled, even as the 1 year...
SWX:IMPN
SWX:IMPNConstruction

Implenia (SWX:IMPN) EPS Beat Reinforces Earnings Led Bullish Narratives

Implenia (SWX:IMPN) has put fresh numbers on the table for FY 2025, with first half revenue of CHF 1.9b and basic EPS of CHF 1.80 setting the tone for how the year is shaping up. The company has seen revenue move from CHF 1.7b in the first half of 2024 to CHF 1.9b in the latest half, while basic EPS shifted from CHF 1.43 to CHF 1.80 over the same periods, creating a results season in which investors are weighing growth prospects against how efficiently those sales are turning into profit. See...
SWX:SCMN
SWX:SCMNTelecom

Swisscom (SWX:SCMN) Valuation Check After Strong Multi‑Period Share Price Gains

What Swisscom’s Recent Share Performance Tells You Swisscom (SWX:SCMN) has seen its share price move in recent weeks, with a 0.8% decline over the past day contrasting with gains over the past week, month and past 3 months. For context, the stock shows a 0.9% return over the past week, 12.3% over the past month and 28.2% over the past 3 months, with a 45.7% total return over the past year. See our latest analysis for Swisscom. The recent pullback in Swisscom’s share price to CHF714.5 comes...
SWX:SFZN
SWX:SFZNLife Sciences

A Look At Siegfried Holding (SWX:SFZN) Valuation After 2025 Results And Leadership Reshuffle

Why Siegfried Holding’s latest earnings and leadership moves matter now Siegfried Holding (SWX:SFZN) has just released its full year 2025 results alongside a senior management reshuffle, a combination that gives you fresh information on both the business performance and how the company is being run. See our latest analysis for Siegfried Holding. The latest CHF82.5 share price comes after a 14.4% 90 day share price return and 10.4% year to date gain, even though the 1 year total shareholder...
SWX:SWON
SWX:SWONElectronic

A Look At SoftwareOne Holding’s Valuation As It Becomes A Global Authorized Google Cloud Distributor

SoftwareOne Holding (SWX:SWON) has been appointed one of the first global authorized Google Cloud distributors, with new distribution rights across 10 launch markets and extended support for partners using Google Cloud services. See our latest analysis for SoftwareOne Holding. The new Google Cloud distribution role arrives after a tough stretch for the share price, with a 30 day share price return of a 13.28% decline and a 90 day share price return of a 23.32% decline, even as the 1 year...
SWX:SENS
SWX:SENSElectronic

A Look At Sensirion Holding’s Valuation As Earnings Approach And AI Sensor Demand Gains Attention

Why Sensirion’s upcoming earnings are on investors’ radar Sensirion Holding (SWX:SENS) is drawing attention ahead of its 10 March 2026 earnings release, as investors watch how demand for sensors in AI and IoT devices shows up in the latest numbers. The focus is on how the company’s cash position and R&D spending support its role as a potential growth play in AI related hardware, and whether new guidance shifts sentiment around the stock. See our latest analysis for Sensirion Holding. Despite...
SWX:ALC
SWX:ALCMedical Equipment

Assessing Alcon (SWX:ALC) Valuation After Earnings Beat, Dividend Proposal And Intraocular Lens Momentum

Alcon (SWX:ALC) is in the spotlight after reporting fourth quarter 2025 earnings, with higher sales and revenue alongside lower net income, while also proposing a dividend and drawing attention for its intraocular lens business. See our latest analysis for Alcon. Alcon’s share price is now at CHF65.24, with a 1 month share price return of 5.29% and a year to date share price return of 2.68%. The 1 year total shareholder return of 21.63% decline contrasts with modest 3 year and 5 year total...
SWX:SREN
SWX:SRENInsurance

How Swiss Re’s 2025 Profit Jump and US$1.50 Billion Buyback Will Impact Swiss Re (SWX:SREN) Investors

In February 2026, Swiss Re reported full-year 2025 net income of US$4,740 million, sharply higher than the prior year, and announced a share repurchase program of up to US$1.50 billion authorized by its Board, running through December 31, 2026 subject to legal and regulatory approvals. Together with the appointment of Anne Lohbeck as chief risk officer for PC Re, these moves highlight Swiss Re's focus on capital return and risk oversight alongside improved profitability. We’ll now examine...
SWX:KNIN
SWX:KNINShipping

Kuehne + Nagel International (SWX:KNIN) Margin Compression Reinforces Bearish Narratives

Kuehne + Nagel International (SWX:KNIN) FY 2025 Results: Margins In Focus After Softer Q4 Kuehne + Nagel International (SWX:KNIN) has wrapped up FY 2025 with fourth quarter revenue of CHF5.95b and basic EPS of CHF1.32, alongside net income of CHF157m. These results frame how investors may assess the full year at a share price of CHF180.45. The company’s quarterly revenue moved from CHF6.76b in Q4 2024 to CHF6.33b in Q1 2025 and then to CHF5.95b in Q4 2025, while basic EPS shifted from CHF2.50...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Valuation Check After Positive Fenebrutinib Phase III Multiple Sclerosis Results

Roche Holding (SWX:ROG) is back in focus after Genentech reported that fenebrutinib met the primary endpoint in the pivotal Phase III FENhance 1 trial in relapsing multiple sclerosis, with statistically significant efficacy versus teriflunomide. See our latest analysis for Roche Holding. The fenebrutinib update lands after a series of drug pipeline milestones and conference appearances. It comes with a 90 day share price return of 15.7% and a 1 year total shareholder return of 22.3%, which...
SWX:SIGN
SWX:SIGNPackaging

SIG Group (SWX:SIGN) H2 Loss Challenges Bullish Earnings Recovery Narrative

Latest FY 2025 Results Snapshot SIG Group (SWX:SIGN) has posted a mixed FY 2025 picture, with second half revenue of €1.7b and a basic EPS loss of €0.47, while trailing twelve month revenue sits at €3.2b alongside a basic EPS loss of €0.23. The company has seen revenue move from €1.8b and basic EPS of €0.29 in the second half of 2024 to €1.7b and a basic EPS loss of €0.47 in the second half of 2025, highlighting pressure on earnings even as the business scale remains large. For investors, the...
SWX:BUCN
SWX:BUCNMachinery

Bucher Industries (SWX:BUCN) Margin Improvement To 8.1% Tests Bearish Earnings Decline Narrative

Bucher Industries (SWX:BUCN) has posted fresh FY 2025 numbers, reporting first half revenue of CHF 1,537.3 million and basic EPS of CHF 13.98. This follows revenue of CHF 1,724 million and EPS of CHF 14.07 in the first half of 2024, and CHF 1,431.5 million with EPS of CHF 8.09 in the second half of 2024. The company has also reported trailing twelve month revenue between CHF 2,914.3 million and CHF 3,155.5 million, with TTM EPS ranging from CHF 22.06 to CHF 23.22, setting the scene for...
SWX:TEMN
SWX:TEMNSoftware

Temenos (SWX:TEMN) Valuation Check After Stronger Full Year Results And Higher Dividend Announcement

Temenos (SWX:TEMN) has drawn fresh attention after releasing its 2025 full year results together with an annual dividend announcement of CHF 1.40 per share, a combination many investors watch closely. See our latest analysis for Temenos. Temenos shares are trading at CHF 72.60, and the latest full year earnings together with the CHF 1.40 dividend announcement appear to have supported a 4.91% 1 month share price return, even though the year to date share price return is a decline of 10.92% and...
SWX:VACN
SWX:VACNMachinery

Assessing VAT Group’s (SWX:VACN) Valuation After Record 2025 Results And Cautious Q1 2026 Outlook

Why VAT Group’s latest earnings matter for shareholders VAT Group (SWX:VACN) reported record 2025 sales, EBITDA, and free cash flow, yet paired those figures with a cautious Q1 2026 revenue outlook that fell short of analyst expectations. That mix of strong historical results and softer near term guidance, along with an upbeat longer term view from management, has put the stock under closer scrutiny as investors reassess how much optimism is already reflected in the current share price. See...
SWX:AMRZ
SWX:AMRZBasic Materials

Amrize Launches EVERtect Concrete To Target Higher Value North American Projects

Amrize (SWX:AMRZ) has introduced its new EVERtect™ high-performance concrete range for customers in North America. The portfolio includes multiple specialized mixes tailored for different construction uses across the U.S. and Canada. The launch expands Amrize’s presence in high-spec concrete solutions for both structural and low-carbon applications. For you as an investor, this move highlights how Amrize is positioning its core materials business around more differentiated, higher-spec...
SWX:ABBN
SWX:ABBNElectrical

Is ABB (SWX:ABBN) Still Attractive After A 46% One Year Share Price Surge?

If you are wondering whether ABB's current share price still makes sense after a strong run, this article breaks down what you are really paying for the business today. ABB shares last closed at CHF 67.20, with returns of 46.1% over 1 year and 181.5% over 5 years. The shorter term picture is mixed, with a 4.8% decline over 7 days but a 9.7% gain year to date. Recent headlines have focused on ABB's ongoing position as a major player in electrification and automation, as well as its exposure...
SWX:ALC
SWX:ALCMedical Equipment

Alcon Lens Milestone Highlights Market Share Question And Valuation Upside Potential

Alcon reports that more than 175 million of its intraocular lenses have been implanted worldwide. The milestone highlights broad adoption of the company’s presbyopia-correcting IOLs across global eye care practices. Alcon plans further intraocular lens launches, subject to regulatory approvals. For investors following Alcon (SWX:ALC), this update comes with the shares trading at CHF63.96 and a value score of 4. The stock shows a 22.3% decline over the past year, while 3-year and 5-year...
SWX:LONN
SWX:LONNLife Sciences

Did Lonza's Inhalable Biologics Push with Iconovo Just Reframe Lonza Group's (SWX:LONN) Investment Narrative?

On 24 February 2026, Iconovo AB announced it had signed a Letter of Intent with Lonza Group to pursue a long-term collaboration around spray dried formulation capabilities for inhalable biologics, building on their existing work on an obesity project. This potential alliance links Lonza’s CDMO scale with Iconovo’s five-platform inhaler technology targeting biologics and high-value respiratory franchises with global turnover of about US$9.00 billion. We’ll now examine how this focus on spray...
SWX:AVOL
SWX:AVOLSpecialty Retail

Is Avolta (SWX:AVOL) Using Share Cancellations To Quietly Redefine Its Capital Efficiency Story?

Avolta AG recently completed the cancellation of about 4.9 million treasury shares, reducing its registered share capital to CHF 708,241,695 across 141,648,339 shares, while continuing to expand its food and beverage footprint at key airports in Italy and Canada. This combination of a tighter share base and integrated travel retail and dining growth highlights Avolta’s focus on capital efficiency alongside strengthening its airport partner relationships. Next, we’ll examine how Avolta’s...